Literature DB >> 4010786

Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation.

R J Shaw, G M Walsh, O Cromwell, R Moqbel, C J Spry, A B Kay.   

Abstract

Eosinophils, a class of granular leukocytes, are prominent in many inflammatory processes, particularly in asthma, certain allergic diseases and during infections with helminthic parasites. Following incubation with the Ca ionophore A23187 (refs 1-4) (a non-physiological agent which circumvents membrane calcium-gating mechanisms), eosinophils generate large amounts of sulphidopeptide leukotrienes, potent inducers of smooth muscle constriction and mucus production. These are now known to represent the activity previously termed 'slow-reacting substance of anaphylaxis' (SRS-A) but attempts to identify a physiological stimulus for SRS-A production by eosinophils have so far been unsuccessful. The cells contain recognized receptors for IgG (Fc) and it is known that they adhere to, and can be activated by, contact with the surface of large organisms such as helminthic larvae. We show here that eosinophils, particularly when activated, produce sulphidopeptide leukotrienes after contact with large particles coated with IgG.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010786     DOI: 10.1038/316150a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  39 in total

Review 1.  Eosinophilic gastroenteritis with ascites: a case report and review of the literature.

Authors:  L M Fenoglio; V Benedetti; C Rossi; A Anania; K Wulhfard; M Trapani; E Scalabrino; G Alberto; D Novero; P Cavalloperin
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

4.  Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

Authors:  W F Owen; J Petersen; K F Austen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Leukotriene B4 and asthma.

Authors:  P E Christie; N C Barnes
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

6.  Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate.

Authors:  A Pérez-Millán; J L Martín-Lorente; A López-Morante; L Yuguero; F Sáez-Royuela
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

7.  Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma.

Authors:  J R Wilkinson; A E Crea; T J Clark; T H Lee
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Oxidative requirement for degranulation of human peripheral blood eosinophils.

Authors:  P Baskar; S H Pincus
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

Review 10.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.